Overview
Quadrivia runs Q, an AI agent that performs clinical process outsourcing for healthcare organizations, handling entire patient journeys from start to finish with clinician oversight. The product automates tasks across access centers, care coordination, scheduling, follow-ups, and patient communications, while configuring itself to each organization’s workflows and serving as a full-service outsourcing partner. Unlike vendors that add tools to a stack, Quadrivia owns the clinical and operational workflow layer and delivers end-to-end delivery operations, acting as a complete service rather than a standalone solution. Its goal is to close the gap between promised care and actual patient care by scaling oversight-enabled automation of patient journeys.
Work here?Claim your company
Simplify's take
What believers are saying
- Quadrivia says Q is live in US and UK organizations as of 2026.
- The website reports 20,000-plus interactions and 25 workflows with 99.6% clinical accuracy.
- Norrsken VC backed Quadrivia in November 2024, funding early commercialization and product iteration.
What critics are saying
- Qu remains in beta, and Quadrivia still seeks collaborators before wider deployment.
- HITRUST r2 is still pending, leaving enterprise healthcare buyers exposed on compliance.
- If clinical outcomes disappoint, health systems cut pilots and the company dies before scale.
What makes Quadrivia unique
- Ali Parsa gives Quadrivia Babylon-era ambition and operator credibility in digital health.
- Q owns end-to-end patient workflows, not point software, across scheduling, outreach, and follow-up.
- Quadrivia pairs AI execution with clinician oversight and mandatory escalation at clinical boundaries.
Help us improve and share your feedback! Did you find this helpful?